Catalyst Pharma sues FDA over approval of cheaper rival drug

105

Catalyst Pharmaceuticals Inc, which has come under fire for the high price tag on its rare disease drug, on Wednesday sued the U.S. Food and Drug Administration to challenge the recent approval of a lower-cost rival drug.

http://feeds.reuters.com/~r/reuters/healthNews/~3/1CvyRycREYk/catalyst-pharma-sues-fda-over-approval-of-cheaper-rival-drug-idUSKCN1TD1L7